Madhav Srivastava
Neurology · Rockford, ILNPI 1770565905
Payments from drug & device makers
Across 233 payments — averaging $18.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$544
- Sanofi$421
- Supernus Pharmaceuticals, Inc.$378
- Biogen$374
- Novartis$288
- Teva Pharmaceuticals USA, Inc.$287
- plus $2K from 31 others
What the payments were for
- Speaking & faculty fees$341%
- Travel & lodging$2345%
- Food & beverage$3,81788%
- Education$2626%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 7 | $544 |
| Sanofi | 18 | $421 |
| Supernus Pharmaceuticals, Inc. | 26 | $378 |
| Biogen | 31 | $374 |
| Novartis | 16 | $288 |
| Teva Pharmaceuticals USA, Inc. | 21 | $287 |
| EMD Serono, Inc. | 8 | $206 |
| Sunovion Pharmaceuticals Inc. | 12 | $171 |
| Johnson & Johnson | 5 | $153 |
| AbbVie(2 entities) | 8 | $145 |
| Genentech USA, Inc. | 14 | $141 |
| Vanda Pharmaceuticals Inc. | 4 | $102 |
| MDD US Operations, LLC | 5 | $100 |
| Catalyst Pharmaceuticals, Inc. | 5 | $97 |
| AstraZeneca | 6 | $92 |
| UCB, Inc. | 6 | $89 |
| Amgen(2 entities) | 5 | $85 |
| Boehringer Ingelheim | 1 | $75 |
| Acadia Pharmaceuticals Inc | 4 | $61 |
| Lundbeck LLC | 3 | $56 |
| Acorda Therapeutics, Inc | 3 | $52 |
| Lilly USA, LLC | 3 | $49 |
| Amneal Pharmaceuticals LLC | 3 | $49 |
| Adamas Pharmaceuticals, Inc. | 2 | $45 |
| Neurocrine Biosciences, Inc. | 3 | $43 |
| Genentech, Inc. | 1 | $40 |
| Jazz Pharmaceuticals Inc. | 2 | $33 |
| Xeris Pharmaceuticals, Inc. | 2 | $23 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $23 |
| Eisai Inc. | 1 | $19 |
| Banner Life Sciences, LLC | 1 | $19 |
| Alnylam Pharmaceuticals Inc. | 1 | $16 |
| Bausch Health US, LLC | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $16 |
| Greenwich Biosciences, Inc. | 1 | $15 |
| Neurelis, Inc. | 1 | $13 |
| SK Life Science, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$442
- AUBAGIO$111
How this compares
$4,347 in reported general payments places this provider in the 65th percentile of 790 neurology providers in Illinois.
Other neurology in Rockford
- Daniel WynnNorthbrook$13.9M
- Concetta ForchettiElk Grove Village$8.5M
- Tatyana SimuniChicago$3.5M
- Danny BegaChicago$2.8M
- Thomas AlaSpringfield$2.4M
- Augusto MiravalleChicago$2.1M
- Leonard Verhagen MetmanChicago$1.8M
- Anthony RederBurr Ridge$1.6M
- Dusan StefoskiChicago$1.5M
- Kourosh RezaniaChicago$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.